• Poster

Agarwal et al.; ARVO 2018

Evaluationg the Lubricationg Effect of Semifluorinated Alkanes on the Ocular Surface

Eickhoff et al.; ARVO 2018

The Pharmacodynamic Effect of LatanoSol Eye Drops on IOP of Normotensive Dogs

Garhoefer et al.; ARVO 2018

Influence of Perfluorohexyloctane Containing Eye Drops on Tear Film Thickness in Patients with Mild to Moderate Dry Eye Disease

Kroesser et al.; ARVO 2018

Ocular and Systemic Distribution of 14C-Perfluorohexyloctane Following Topical Ocular Administration to Rabbits

Agarwal et al.; IOIS 2017

Semifluorinated Alkanes Enhance the Lipid Layer for Dry Eye Therapy

Fischer et al.; EVER 2017

Exploratory Ocular Surface Distribution Studies of Azithromycin Formulations Based on Semifluorinated Alkanes

Torkildsen et al.; AAO 2017

A Clincal Phase 2 Study to Assesss Safety, Efficacy, and Tolerability of CyclASol® for the Treatment of Dry Eye Disease

Agarwal et al.; EVER 2016

Semi-Fluorinated Alkanes for Topical Delivery of Cyclosporine A

Gehlsen et al.; ARVO 2016

Omega-3 Fatty Acids Using F6H8-Carrier as Topical Therapy in Experimental Dry Eye Disease

Kaercher et al.; TFOS 2016

NovaTears® as New Therapy in Dry Eye: Results frorm Three Prospective, Multicenter, Non-Interventional Studies in Different Patient Populations

Messmer et al.; DOG 2016

Semifluorierte Alkane als Therapie bei Meibomdrüsen-Dysfunktion: Ergebnisse einer prospektiven, multizentrischen Beobachtungsstudie

Gehlsen et al.; ARVO 2015

Cyclosporine A Using F4H5 as Liquid Drug Carrier is Effectie in Treating Experimental Dry Eye Disease